Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University: Carcinoma, Ovarian Epithelial trials

The registry lists 14 Carcinoma, Ovarian Epithelial studies with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 3No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer PatientsRecruitingNCT06622798
• Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image DataRecruitingNCT06533709
• Administration of Hyperthermic Intraperitoneal Chemotherapy in the General WardNot yet recruitingNCT06277947Not applicable
• A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omicsRecruitingNCT05251883
• Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian CancerCompletedNCT06697613
• Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion ChemotherapyStatus unknownNCT05877911Phase 2
• Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)Status unknownNCT05693987
• Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)Status unknownNCT05693974
• A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With CisplatinStatus unknownNCT05620654Phase 1
• The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort StudyStatus unknownNCT05265117
• Efficacy of Neoadjuvant Hyperthermic Intraperitoneal Chemotherapy in Advanced High-grade Serous Ovarian Cancer (the NHIPEC Trial)Status unknownNCT05246020Phase 2
• Study on the Consistency Evaluation of Organoids Used in the Clinical Treatment of Ovarian Cancer With Anti-tumor DrugsStatus unknownNCT05175326
• Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.CompletedNCT05130515Phase 2
• Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian CancerStatus unknownNCT04511481